Inflammatory bowel disease serologies in ankylosing spondylitis patients: A pilot study

Arthritis Research and Therapy

Volumn 11, Issue 6, 2009, Pages

  Mundwiler, Matthew L ^a   Mei, Ling ^b   Landers, Carol J ^b   Reveille, John D ^c   Targan, Stephan ^b   Weisman, Michael H ^b  

^a Rockford Orthopedic Associates   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI FLAGELLIN ANTIBODY; ANTI I2 ANTIBODY; ANTI SACCHAROMYCES CEREVISIAE ANTIBODY; BIOLOGICAL MARKER; FUNGUS ANTIBODY; HLA ANTIGEN; HLA B27 ANTIGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; NEUTROPHIL CYTOPLASMIC ANTIBODY; OUTER MEMBRANE PROTEIN C; UNCLASSIFIED DRUG; BACTERIUM ANTIBODY; CBIR1 FLAGELLIN; FLAGELLIN; PFIT PROTEIN, PSEUDOMONAS FLUORESCENS; PORIN; SUPERANTIGEN;

ADULT; ANKYLOSING SPONDYLITIS; ANTIBODY RESPONSE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CROHN DISEASE; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE DURATION; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR DYNAMICS; MUCOSAL IMMUNITY; PILOT STUDY; PROTEIN FUNCTION; SCORING SYSTEM; SEROLOGY; BLOOD; IMMUNOLOGY; MIDDLE AGED; SACCHAROMYCES CEREVISIAE;

ADULT; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTIBODIES, BACTERIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLAGELLIN; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; PILOT PROJECTS; PORINS; SACCHAROMYCES CEREVISIAE; SPONDYLITIS, ANKYLOSING; SUPERANTIGENS; YOUNG ADULT;

EID: 77952466960     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar2866     Document Type: Article

References (20)

1. Helmick CG, Felson DT, Lawrence RC, Gabriel S, Hirsch R, Kwoh CK, Liang MH, Kremers HM, Mayes MD, Merkel PA, Pillemer SR, Reveille JD, Stone JH. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part I. Arthritis Rheum. 2008, 58:15-25. 10.1002/art.23177, 18163497.
2. Guignard S, Gossec L, Dougados M. Diagnostic and classification criteria. Ankylosing Spondylitis and the Spondyloarthropathies 2006, 132-144. Philadelphia: Mosby, Weisman MH, Reveille JD, Van der Heijde D, 1.
3. Pang SW, Davis JC. Clinical aspects of ankylosing spondylitis. Ankylosing Spondylitis and the Spondyloarthropathies 2006, 145-153. Philadelphia: Mosby, Weisman MH, Reveille JD, van der Heijde D, 1.
4. Mielants H, Bosch F. Inflammatory bowel disease spondyloarthritis: epidemiology, clinical features, and treatment. Ankylosing spondylitis and the spondyloarthropathies 2006, 65-74. Philadelphia: Mosby, Weisman MH, Reveille JD, Van der Heijde D, 1.
5. Duerr RH, Taylor KD, Brant SR, Rioux JD, Silverberg MS, Daly MJ, Steinhart AH, Abraham C, Regueiro M, Griffiths A, Dassopoulos T, Bitton A, Yang H, Targan S, Datta LW, Kistner EO, Schumm LP, Lee AT, Gregersen PK, Barmada MM, Rotter JI, Nicolae DL, Cho JH. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 2006, 314:1461-1463. 10.1126/science.1135245, 17068223.
6. Rahman P, Inman RD, Gladman DD, Reeve JP, Peddle L, Maksymowych WP. Association of interleukin-23 receptor variants with ankylosing spondylitis. Arthritis Rheum 2008, 58:1020-1025. 10.1002/art.23389, 18383363.
7. Landers C, Cohavy O, Misra R, Yang H, Lin Y-C, Braun J, Targan S. Selected loss of tolerance evidenced by crohn's diease-associated immune responses to auto- and microbial antigens. Gastroenterology 2002, 123:689-699. 10.1053/gast.2002.35379, 12198693.
8. Aydin SZ, Atagunduz M, Temei M, Bicakcigil M, Tasan D, Direskeneli H. Anti-Saccharomyces cerevisiae antibodies (ASCA) in spondyloarthropathies: a reassessment. Rheumatology 2008, 47:142-144. 10.1093/rheumatology/kem324, 18160421.
9. Torok H-P, Glas J, Gruber R, Brumberger V, Strasser C, Kellner H, Marker-Hermann E, Flowaczny C. Inflammatory bowel disease-specific autoantibodies in HLA-B27-associated spondyloarthropathies: increased prevalence of ASCA and pANCA. Digestion 2004, 70:49-54. 10.1159/000080081, 15308872.
10. Riente L, Chimenti D, Pratesi F, Delle Sedie A, Tommasi S, Tommasi C, Bombardieri S, Migliorini P. Antibodies to tissue transglutaminase and Saccharomyces cerevisiae in ankylosing spondylitis and psoriatic arthritis. J Rheumatol 2004, 31:920-924.
11. Gensler LS, Ward MM, Reveille JD, Learch TJ, Weisman MH, Davis JC. Clinical, radiographic and functional differences between juvenile-onset and adult-onset ankylosing spondylitis: results from the PSOAS cohort. Ann Rheum Dis 2008, 67:233-237. 10.1136/ard.2007.072512, 17604288.
12. Lee W, Reveille JD, Davis JC, Learch TJ, Ward MM, Weisman MH. Are there gender differences in severity of ankylosing spondylitis? Results from the PSOAS cohort. Ann Rheum Dis 2006, 66:633-638. 10.1136/ard.2006.060293, 17127685.
13. Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York Criteria. Arthritis Rheum 1984, 27:361-368. 10.1002/art.1780270401, 6231933.
14. Papadakis KA, Yang H, Ippoliti A, Mei L, Elson CO, Hershberg RM, Vasiliauskas EA, Fleshner P, Abreu MT, Taylor K, Landers C, Rotter JI, Targan S. Anti-flagellin (CBir1) phenotypic and genetic crohn's disease associations. Inflamm Bowel Dis 2007, 13:524-530. 10.1002/ibd.20106, 17260364.
15. Mow WS, Vasiliauskas EA, Lin Y-C, Fleshner P, Papadakis KA, Taylor K, Landers C, Abreu MT, Rotter JI, Yang H, Targan S. Association of antibody responses to microbial antigens and complications of small bowel crohn's disease. Gastroenterology 2004, 126:414-424. 10.1053/j.gastro.2003.11.015, 14762777.
16. Targan SR, Landers CJ, Yang H, Lodes MJ, Cong Y, Papadakis KA, Vasiliauskas EA, Elson CO, Hershberg RM. Antibodies to CBir1 define a unique response that is associated independently with complicated crohn's disease. Gastroenterology 2005, 128:2020-2028. 10.1053/j.gastro.2005.03.046, 15940634.
17. Devlin S, Yang H, Ippoliti A, Taylor K, Landers C, Xiaowen S, Abreu MT, Papadakis KA, Vasiliauskas EA, Melmed G, Fleshner P, Mei L, Rotter JI, Targan S. NOD2 variants and antibody response to microbial antigens in crohn's disease patients and their unaffected relatives. Gastroenterology 2007, 132:576-586. 10.1053/j.gastro.2006.11.013, 17258734.
18. Quinton J-F, Sendid B, Reumaux D, Duthilleul P, Cortot A, Grandbastien B, Charrier G, Targan SR, Colombel J-F, Poulain D. Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel diease: prevalence and diagnostic role. Gut 1998, 42:788-791. 1727156, 9691915.
19. Vasiliauskas EA, Plevy SE, Landers CJ, Binder SW, Ferguson DM, Yang H, Rotter JI, Vidrich A, Targan SR. Perinuclear antineutrophil cytoplasmic antibodies in patients with crohn's disease define a clinical subgroup. Gastroenterology 1996, 110:1810-1819. 10.1053/gast.1996.v110.pm8964407, 8964407.
20. Mei L, Targan S, Landers C, Dutridge D, Ippoliti A, Vasiliauskas EA, Papadakis KA, Fleshner P, Rotter JI, Yang H. Familial expression of anti-Escherichia coli outer membrane porin C in relatives of patients with crohn's disease. Gastroenterology 2006, 130:1078-1085. 10.1053/j.gastro.2006.02.013, 16618402.